NM_001318895.3:c.523A>C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001318895.3(FHL2):c.523A>C(p.Thr175Pro) variant causes a missense change. The variant allele was found at a frequency of 0.000122 in 1,610,804 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001318895.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152182Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000165 AC: 40AN: 242218Hom.: 0 AF XY: 0.000191 AC XY: 25AN XY: 130874
GnomAD4 exome AF: 0.000118 AC: 172AN: 1458504Hom.: 0 Cov.: 32 AF XY: 0.000127 AC XY: 92AN XY: 725172
GnomAD4 genome AF: 0.000158 AC: 24AN: 152300Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:2
The c.523A>C (p.T175P) alteration is located in exon 7 (coding exon 4) of the FHL2 gene. This alteration results from a A to C substitution at nucleotide position 523, causing the threonine (T) at amino acid position 175 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
The p.Thr175Pro variant in FHL2 has not been previously reported in individuals with cardiomyopathy, but has been identified in 10/48278 European chromosomes an d 5/7254 Latino chromosomes by the Exome Aggregation Consortium (ExAC, http://ex ac.broadinstitute.org; dbSNP rs200116659). Computational prediction tools and co nservation analysis suggest that this variant may impact the protein, though thi s information is not predictive enough to determine pathogenicity. In summary, t he clinical significance of the p.Thr175Pro variant is uncertain. -
Primary dilated cardiomyopathy Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 175 of the FHL2 protein (p.Thr175Pro). This variant is present in population databases (rs200116659, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with FHL2-related conditions. ClinVar contains an entry for this variant (Variation ID: 228690). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt FHL2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at